Discontinuation report SUPREFACT DEPOT 3 MONTHS

Last updated on 2024-07-10 History
Report ID 228166
Drug Identification Number 02240749
Brand name SUPREFACT DEPOT 3 MONTHS
Common or Proper name buserelin acetate implant
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) BUSERELIN
Strength(s) 9.45MG
Dosage form(s) IMPLANT
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 applicator
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date
Remaining supply date
Discontinuation status Reversed
Discontinuation decision reversal Yes
Information on remaining supply
Company comments
Health Canada comments Product will be in shortage with an unknown end date
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-05-16 English Compare
v2 2024-05-16 French Compare
v3 2024-05-17 English Compare
v4 2024-07-10 English Compare
v5 2024-07-10 English Compare
v6 2024-07-10 French Compare

Showing 1 to 6 of 6